Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
10.05
|
10.38
|
8.57
|
8.50
|
11.30
|
10.11
|
|
|
1 551 897.34
|
1 089.00
|
8.00
|
8.20
|
7.82
|
7.59
|
8.74
|
8.34
|
|
|
295 189.79
|
355.00
|
7.21
|
9.20
|
6.75
|
6.75
|
7.65
|
7.65
|
|
|
420 239.05
|
559.00
|
7.15
|
7.31
|
5.10
|
5.10
|
7.78
|
7.10
|
|
|
3 166 472.94
|
4 822.00
|
4.77
|
5.15
|
4.16
|
4.15
|
5.76
|
5.00
|
|
|
431 822.77
|
792.00
|
3.88
|
4.22
|
3.51
|
3.32
|
4.11
|
4.07
|
|
|
171 634.61
|
313.00
|
3.41
|
9.20
|
3.66
|
3.39
|
3.66
|
3.41
|
|
|
372 799.17
|
142.00
|
3.52
|
|
3.75
|
3.695
|
3.85
|
3.76
|
|
|
37 890.48
|
83.00
|
3.00
|
|
3.87
|
3.75
|
4.03
|
3.77
|
|
|
14 743.36
|
48.00
|
3.52
|
9.20
|
3.72
|
3.72
|
4.11
|
3.92
|
|
|
42 263.68
|
89.00
|
Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.